A novel murine model of myeloproliferative disorders generated by overexpression of the transcription factor NF-E2
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A novel murine model of myeloproliferative disorders generated by overexpression of the transcription factor NF-E2
Authors
Keywords
-
Journal
JOURNAL OF EXPERIMENTAL MEDICINE
Volume 209, Issue 1, Pages 35-50
Publisher
Rockefeller University Press
Online
2012-01-10
DOI
10.1084/jem.20110540
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Deciphering the molecular and biologic processes that mediate histone deacetylase inhibitor-induced thrombocytopenia
- (2011) M. J. Bishton et al. BLOOD
- Megakaryocytes possess a functional intrinsic apoptosis pathway that must be restrained to survive and produce platelets
- (2011) Emma C. Josefsson et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Multi-parameter fluorescence-activated cell sorting and analysis of stem and progenitor cells in myeloid malignancies
- (2010) Britta Will et al. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- AML1 is overexpressed in patients with myeloproliferative neoplasms and mediates JAK2V617F-independent overexpression of NF-E2
- (2010) W. Wang et al. BLOOD
- Sequential treatment of CD34+ cells from patients with primary myelofibrosis with chromatin-modifying agents eliminate JAK2V617F-positive NOD/SCID marrow repopulating cells
- (2010) X. Wang et al. BLOOD
- Conditional expression of heterozygous or homozygous Jak2V617F from its endogenous promoter induces a polycythemia vera-like disease
- (2010) H. Akada et al. BLOOD
- JAK2 V617F impairs hematopoietic stem cell function in a conditional knock-in mouse model of JAK2 V617F-positive essential thrombocythemia
- (2010) J. Li et al. BLOOD
- Prognosis of Secondary Acute Myeloid Leukemia is Affected by the Type of the Preceding Hematologic Disorders and the Presence of Trisomy 8
- (2010) Y. Koh et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Safety and Efficacy of INCB018424, a JAK1 and JAK2 Inhibitor, in Myelofibrosis
- (2010) Srdan Verstovsek et al. NEW ENGLAND JOURNAL OF MEDICINE
- Identification of a myeloid committed progenitor as the cancer-initiating cell in acute promyelocytic leukemia
- (2009) F. C. Guibal et al. BLOOD
- Phase 2 study of CEP-701, an orally available JAK2 inhibitor, in patients with primary or post-polycythemia vera/essential thrombocythemia myelofibrosis
- (2009) F. P. S. Santos et al. BLOOD
- NF-E2 overexpression delays erythroid maturation and increases erythrocyte production
- (2009) Manuel Mutschler et al. BRITISH JOURNAL OF HAEMATOLOGY
- Correction of the Abnormal Trafficking of Primary Myelofibrosis CD34+ Cells by Treatment with Chromatin-Modifying Agents
- (2009) X. Wang et al. CANCER RESEARCH
- Conventional cytogenetics in myelofibrosis: literature review and discussion
- (2009) Kebede Hussein et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Chromatin Architecture and Transcription Factor Binding Regulate Expression of Erythrocyte Membrane Protein Genes
- (2009) L. A. Steiner et al. MOLECULAR AND CELLULAR BIOLOGY
- JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms
- (2009) Amy V Jones et al. NATURE GENETICS
- Dual role for the methyltransferase G9a in the maintenance of -globin gene transcription in adult erythroid cells
- (2009) C.-P. Chaturvedi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Copy number alterations in childhood acute lymphoblastic leukemia and their association with minimal residual disease
- (2008) Doris Steinemann et al. GENES CHROMOSOMES & CANCER
- Life expectancy and prognostic factors in the classic BCR/ABL-negative myeloproliferative disorders
- (2008) F Cervantes et al. LEUKEMIA
- Enhanced histone deacetylase enzyme activity in primary myelofibrosis
- (2008) Jen Chin Wang et al. LEUKEMIA & LYMPHOMA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation